Markets ALAB

Why Astera Labs Stock Plummeted This Week

Key Points

Astera Labs (NASDAQ: ALAB) stock got hit with a double-digit sell-off across this week's trading. The company's share price fell 19.3% over the period. Meanwhile, the S&P 500 and the Nasdaq Composite declined 0.3% and 0.7%, respectively.

While there wasn't any fresh, business-specific news behind Astera Labs' sell-off this week, the company's valuation headed lower in response to widespread valuation concerns that impacted the market. Declines for the S&P 500 and the Nasdaq Composite were relatively mild in the grand scheme of things.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

A chart line moving downward in front of stock charts and coins.

Image source: Getty Images.

Astera Labs stock sinks as investors heed valuation warning

Speaking in Rhode Island earlier this week, Federal Reserve Chair Jerome Powell suggested that stocks look highly valued by many metrics. The comments came in reference to the Fed's recent decision to cut the U.S.'s benchmark interest rates.

While lower rates typically correspond with stronger performance for stocks, Powell's comments raised concerns among investors that equity valuations could already be unreasonably stretched. The response to Powell's statements from investors was widespread selling out of growth-dependent stocks, and Astera saw a big valuation contraction as part of the trend.

What's next for Astera Labs?

Even though Astera Labs stock got hit with a big valuation pullback this week, its share price is still up 49% in 2025. The company's valuation has marched higher, as artificial intelligence (AI) trends have helped push demand for its chips and other connectivity solutions have risen at an encouraging pace, potentially setting the stage for long-term valuation expansion.

With its Q2 update, Astera Labs guided for sales in the current quarter to come in between $203 million and $210 million -- suggesting year-over-year growth of roughly 83% at the midpoint of the guidance range. While Astera Labs is posting strong expansion momentum, the stock still comes with a high degree of risk, with the company currently valued at approximately 42 times this year's expected sales.

Should you invest $1,000 in Astera Labs right now?

Before you buy stock in Astera Labs, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Astera Labs wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $652,872!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,092,280!*

Now, it’s worth noting Stock Advisor’s total average return is 1,062% — a market-crushing outperformance compared to 189% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of September 22, 2025

Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The Motley Fool
Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.
Visit Fool.com for more market news More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available